The loss of MGA in lung adenocarcinoma cells, which occurs in ~8% of lung adenocarcinoma patients, was shown to lead to an upregulation of MYC- and E2F6-target genes, resulting in an increase in cancer cell proliferation and invasiveness [11, 12]. The gene discussed is E2F6; the disease is lung adenocarcinoma.